Morning Market Movers
January 08, 2014 at 09:58 AM EST
ARCA biopharma (NASDAQ: ABIO ) jumped 38.89% to $2.50 after the company announced the FDA acceptance of Gencaro companion diagnostic test IDE. NuPathe (NASDAQ: PATH ) rose 34.67% to $4.35 after the company received an offer of $3.65 per share from Teva Pharmaceutical Industries (NYSE: TEVA ). Dataram (NASDAQ:
